In the 70 billion won-shaped hemostatic market, Baxter Floseal is likely to surpass 30 billion won in sales this year, and is expected to rank first for the third consecutive year. According to the drug distribution performance data, Baxter Flossal's sales reached 25.3 billion won and Hyundai Pharmaceutical's Tachosil's sales reached 12.5 billion won until the third quarter of this year, ranking first and second, respectively. GC Pharma s Greenplast Q and Tisseel posted 8.8 billion won and 7.6 billion won in sales. The Beri Plast P Combi Set in Germany remained in the bottom ranks with 1.8 billion won in performance. Floseal's breakthrough has seen 23.2 billion won and 27.3 billion won (2021) from 2020, far exceeding